Due Diligence

With current or potential investments, it is critical to understand the reimbursement implications that can impact sales projections, revenue growth and profit margins.  Without a comprehensive understanding of the critical reimbursement issues your product will face, investment decision makers will overlook a powerful market factor.  Whether you are an investor or are seeking funding, it is critical to do due diligence that integrates reimbursement intelligence into overall business planning. 

To assist investors with the due diligence process, RI offers the following services from the payer perspective:

• Evaluation of product vs. current standard of care
• Customer segment specific evaluation (Medicare vs. Commercial) from a payer perspective
• Pricing studies
• Contracting analysis
• Competitive intelligence on competitors contracting and rebate strategy
• Business forecasting based upon reimbursement/planning analysis
• Potential formulary position, restrictions and reimbursement
• Need for health outcomes data demonstrating medical cost offsets

RI provides objective, third party advisement based upon our in-depth analysis.  RI senior staff are highly experienced in most therapeutic categories and can provide immediate valuable insights to the due diligence process.

<< Back